Feline Injection-Site Sarcoma (FISS)
Also known as: FISS, Vaccine-Associated Sarcoma, Injection-Site Fibrosarcoma
⚠ Emergency Warning Signs
Not typically an emergency condition, though rapid growth or significant pain warrants prompt veterinary evaluation.
Overview
An aggressive, locally invasive tumor that can develop at the site of a prior injection (historically most associated with certain vaccines, particularly rabies and FeLV vaccines, though the underlying mechanism is now understood to potentially relate to chronic local inflammation from various injectable substances, not vaccines specifically or exclusively) — a genuinely important condition that has directly shaped current vaccination practice recommendations, including preferred injection site locations.
Symptoms
- Firm, persistent lump at an injection site
- Lump growing after initial period
- Lump exceeding 2cm or persisting beyond 3 months
Causes
Believed to result from chronic local inflammation at an injection site in a genetically susceptible individual cat, triggering a malignant transformation of local tissue over time; while historically strongly associated with certain vaccines, the current understanding recognizes this can occur at the site of various injections, not exclusively vaccines. FISS is a fibrosarcoma developing at a prior injection site (historically most associated with certain vaccines, though the exact relationship and which specific factors trigger it in a given cat remain incompletely understood), thought to relate to chronic local inflammation at the injection site eventually triggering malignant transformation in a genuinely small proportion of cats — the practice of injecting vaccines in the lower limb rather than between the shoulder blades in some current protocols specifically reflects efforts to make any resulting tumor more amenable to complete surgical removal if this rare complication does occur.
Risk Factors
A history of injection (of any type, though certain vaccines were the original and most studied association) at a given site; genetic susceptibility likely plays a role in why only a small proportion of cats receiving injections ever develop this condition, though this isn't fully characterized at an individual level.
Transmission
Not applicable — not an infectious or contagious condition.
Incubation Period
Not applicable in the infectious sense; the tumor typically develops over months to years following the triggering injection.
Disease Stages & Progression
Often begins as a firm swelling at a previous injection site, which can be mistaken initially for a normal, transient post-injection reaction — this is exactly why persistent or growing swelling at an injection site (rather than one that resolves within the expected weeks) needs specific attention. Once established, these tumors tend to be locally aggressive, invading surrounding tissue.
Early Warning Signs
A firm lump at a previous injection site that persists beyond a few weeks, continues to grow, or appears months after the injection was given — current recommendations specifically flag any injection-site lump persisting beyond 3 months, exceeding 2cm in size, or growing after an initial period as warranting biopsy (sometimes summarized as the '3-2-1 rule'). A mass at a prior injection site that persists beyond 3 months, grows larger than 2cm, or continues enlarging after an initial post-injection swelling would be expected to resolve are the specific warning signs veterinary guidelines highlight — a small, non-growing lump at an injection site during the first few weeks is common and usually not concerning, but the pattern described above warrants prompt biopsy.
Advanced Symptoms
A larger, more invasive mass, and given this tumor type's tendency for local invasion, potential involvement of deeper tissue layers, which affects how extensive surgical treatment needs to be.
Diagnostic Methods
Biopsy of any persistent or growing injection-site lump provides definitive diagnosis — this is genuinely important to pursue proactively given current guidelines, rather than assuming a lump at an injection site is a normal, self-resolving reaction.
Veterinary Examination Process
Careful assessment and measurement of any injection-site lump, with specific attention to size, growth pattern, and how long it's persisted — informing whether the '3-2-1 rule' criteria for biopsy are met.
Recommended Lab Tests
Not specific to this condition; biopsy is the key diagnostic test.
Diagnostic Imaging
CT or MRI imaging is valuable for assessing the tumor's full extent before surgical planning, given how important complete removal is for this specific, locally aggressive tumor type; chest X-rays check for the less common but possible spread to the lungs.
Blood Test Indicators
Not specific to this condition; pre-treatment bloodwork assesses overall health.
Biopsy / Histopathology
Essential — biopsy confirms the diagnosis and helps characterize the tumor for treatment planning.
Differential Diagnoses
A normal, transient post-injection reaction (which typically resolves within weeks), a benign lipoma or other mass, and other tumor types — biopsy is essential to distinguish these, particularly given how much more aggressive treatment for a true injection-site sarcoma needs to be compared to a benign alternative.
Home Monitoring Guidance
Monitoring an injection-site lump's size and persistence at home is genuinely useful (tracking against the 3-2-1 rule criteria), but any lump meeting those criteria needs veterinary biopsy rather than continued home observation alone.
Veterinary Treatment Options
Aggressive, wide surgical excision — removing substantially more surrounding tissue than would be typical for many other tumor types — is the cornerstone of treatment, reflecting how locally invasive these tumors characteristically are and how much incomplete removal increases recurrence risk. Radiation therapy is often recommended alongside surgery, either before or after, to address microscopic tumor extension beyond what's visible. Chemotherapy may be considered in some cases as well. Given this tumor's locally aggressive growth pattern, wide surgical excision (often more extensive than the visible tumor alone would suggest is needed) combined with radiation therapy offers the best chance at long-term control — this combination approach reflects how important complete removal of microscopic tumor extension is for this specific cancer.
Surgery Requirements
Aggressive, wide surgical excision is the standard approach, often more extensive than owners initially expect given how important complete removal with clear margins is for this specific tumor type's behavior.
Recovery Timeline
Recovery from the necessarily extensive surgery is typically several weeks; radiation therapy, where pursued, adds its own treatment course and recovery considerations.
Possible Complications
Local recurrence is a genuine, well-recognized risk even with aggressive treatment, given this tumor type's locally invasive nature; spread to the lungs is possible though less common than local recurrence as the primary concern.
Long-Term Management
Regular follow-up monitoring for local recurrence is important given the meaningful recurrence risk even after aggressive initial treatment.
Prevention
Current vaccination guidelines (developed specifically in response to this condition) recommend giving vaccines in specific locations (such as further down a limb rather than between the shoulder blades) partly to make any resulting tumor more amenable to complete surgical removal if it does occur, and recommend against unnecessary repeated vaccination beyond what's actually needed for a given cat's risk profile and local disease prevalence.
Vaccination Availability
Not applicable to this condition itself — this is a rare potential complication of injections (historically most studied with certain vaccines) rather than something vaccines prevent.
Prognosis
Guarded, reflecting this tumor type's genuine tendency for local recurrence even after aggressive treatment; outcomes are generally better with early detection and sufficiently wide initial surgical excision (sometimes combined with radiation) than with a more conservative initial approach that leaves microscopic tumor behind.
References
Vaccine-Associated Feline Sarcoma Task Force; American Association of Feline Practitioners (AAFP); World Small Animal Veterinary Association (WSAVA) vaccination guidelines.
Medications Used
- Chemotherapy, in select cases
- Pain management, particularly around extensive surgery
Estimated Treatment Cost by Country
| Country | Estimated Cost Range | Notes |
|---|---|---|
| IN | 25,000–100,000 INR | |
| US | 2,500–9,000 USD | |
| UK | 2,200–8,000 GBP | |
| AU | 3,000–10,000 AUD | |
| JP | 400,000–1,200,000 JPY | |
| DE | 2,200–8,500 EUR | |
| BR | 5,000–18,000 BRL |
Frequently Asked Questions
Does this mean I shouldn't vaccinate my cat?
No — this is a genuinely rare complication relative to the enormous protective benefit vaccines provide, and modern vaccination guidelines and practices have been specifically adjusted in response to this condition (including injection site selection and avoiding unnecessary over-vaccination) to reduce risk while preserving the real, substantial benefits of core vaccination; this is a case for informed practice, not avoidance.
What is the '3-2-1 rule' my vet mentioned?
It's a practical guideline for when an injection-site lump should be biopsied: if it persists beyond 3 months after the injection, is larger than 2cm, or is growing 1 month after the injection, biopsy is recommended — this helps catch injection-site sarcoma early, when complete surgical removal is more achievable, rather than waiting to see if a lump simply resolves on its own.